Skip to main content
Veterinary Medicines

Amoksiklav, 500/125mg/g, Prášek pro podání v pitné vodě

Authorised
  • Amoxicillin
  • Clavulanic acid

Product identification

Medicine name:
Amoksiklav, 500/125mg/g, Prášek pro podání v pitné vodě
Active substance:
  • Amoxicillin
  • Clavulanic acid
Target species:
  • Pig
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Amoxicillin
    500.00
    milligram(s)
    /
    1.00
    gram(s)
  • Clavulanic acid
    125.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Pig
      • Meat and offal
        1
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Available in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lek Pharmaceuticals d.d.
  • Lek Pharmaceuticals d.d.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/069/98-C
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 14/11/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 7/03/2025

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 14/11/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."